Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC
HTML-код
- Опубликовано: 15 окт 2023
- Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC
Chair, Jessica Donington, MD, David H. Harpole Jr., MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC/AAPA activity titled “Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC: Leveraging Science, Enhancing Collaboration, and Improving Outcomes With Neoadjuvant and/or Adjuvant Checkpoint Inhibition.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/HXS865. CME/MOC/AAPA credit will be available until October 22, 2024.
